⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PGEN News
Precigen, Inc. Common Stock
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
accessnewswire.com
PGEN
Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Community Voices
prnewswire.com
PGEN
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Responses Beyond 4 Years
prnewswire.com
PGEN
Sage Growth Partners Strengthens Digital Marketing Capabilities with Hiring of Raheim Bundle
prnewswire.com
GEHC
PGNY
NXPI
PGEN
PHG
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
prnewswire.com
PGEN
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference
prnewswire.com
PGEN
Form 8-K
sec.gov
PGEN
Precigen Reports First Quarter 2026 Financial Results and Business Updates
prnewswire.com
PGEN
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
accessnewswire.com
PGEN
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
prnewswire.com
PGEN